CD8+ T cells, as preferred cancer-targeting immunotherapy cells, through exocytosis and the release of perforin-granzyme and activation of caspases via the release of cytochrome c in cancer cells, contribute to tumor cell apoptosis (Farhood et al., 2019). This evidence concerns the gene CD8A and cancer.